CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  News  /  Media Stories

MEDIA STORIES

Biosimilar drugs can help us reach $1 billion target soon

16-Jun-2020

external_link-01
Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020

 06-Jun-2020

external_link-01
Covid provides larger opportunity to shape the biosimilar landscape

 19-May-2020

external_link-01
Will invest Rs2,000 crore in small molecules in 3-4 years

 16-May-2020

external_link-01
Biocon wins patent case against Sanofi

 12-Mar-2020

external_link-01
Biocon’s cancer biosimilar gets US FDA acceptance for review

 10-Mar-2020

external_link-01
Biocon chief is EY entrepreneur for 2019

 22-Feb-2020

external_link-01
Biocon Biologics Eyes $200M. Plans IPO in 2 Yrs: Mazumdar-Shaw

 27-Jan-2020

external_link-01
Biocon Q3 PBT up 9%

 24-Jan-2020

external_link-01
Biocon optimistic about hitting $1 billion in revenue by FY22 on back of new launches

 08-Jan-2020

external_link-01
Biocon, partner Mylan launch oncology biosimilar trastuzumab in US

11-Dec-2019

external_link-01
USFDA nod to Biocon’s new Bengaluru unit

28-Nov-2019

external_link-01
Biocon, Mylan get nod for pegfilgrastim drug

28-Nov-2019

external_link-01
Indian company makes it to top 10 best employers in biotech category

30-Oct-2019

external_link-01
Insulin at ₹7 will be a gamechanger for us

26-Oct-2019

external_link-01
Life-enabling product like insulin should be made affordable: Shaw

28-Sep-2019

external_link-01
Biocon plans to halve insulin prices

27-Sep-2019

external_link-01
Biocon sets $1 billion target for biologics business

25-Oct-2019

external_link-01
Biocon subsidiary acquires Pfizer’s R&D facility in Chennai

25-Sep-2019

external_link-01
Blueprint for a Healthy India

25-Sep-2019

external_link-01
Ramp-up of biosimilar portfolio to boost Biocon

22-Aug-2019

external_link-01
Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO

 30-Jul-2019

external_link-01
Biocon’s net rises 86%, revenue 25%

 26-Jul-2019

external_link-01
Biocon net profit grows 72%

 25-Jul-2019

external_link-01
Biosimilars, research key drivers for Biocon

 18-Jun-2019

external_link-01
Trastuzumab’s US launch will be a big opportunity for Biocon-Mylan: Shaw

 18-Jun-2019

external_link-01
Biocon’s Bengaluru biologics units get European agency nod

 15-Jun-2019

external_link-01
The First Lady of Biotech

 08-Jun-2019

external_link-01
Biocon, Mylan to present data for Ogivri at ASCO meeting

 30-May-2019

external_link-01
Canada clears Mylan & Biocon’s Biosimilar

 23-May-2019

external_link-01
Biologics to boost Biocon business, say analyst

 20-May-2019

external_link-01
Biocon drug gets commercial rights to global markets

 09-May-2019

external_link-01
Biosimilars to help Biocon hit $1bn revenue in FY20

 30-Apr-2019

downloadicon-01
Biologics, research services the golden goose for Biocon

 27-Apr-2019

external_link-01
Biocon Q4 net profit up 64% to ₹213.7 crore

 26-Apr-2019

external_link-01
Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia

 18-Apr-2019

external_link-01
Violence,EVM glitches, missing names:Rocky start to election

 12-Apr-2019

external_link-01
Research must be promoted in colleges

 08-Apr-2019

external_link-01
ET Prime celebrates Women’s Excellence in Business & Innovation

 05-Apr-2019

external_link-01
Breakthrough innovation is taking place but we’re not leveraging it

 05-Apr-2019

external_link-01
Kiran Mazumdar-Shaw conferred with Honorary Doctorate

 04-Apr-2019

external_link-01
Biocon Biologics India appoints Dr. Christiane Hamacher as CEO

 01-Apr-2019

external_link-01
Biocon chief stresses on gender equality

 29-Mar-2019

external_link-01
Kiran back as Infy’s independent director

 19-Mar-2019

external_link-01
Govt Should Scale Up Philanthropic Capital

 18-Mar-2019

external_link-01